19-hydroxy-PGE2,
19-hydroxyprostaglandin E2,
19(R)-hydroxy-PGE2,
19-Hydroxy-PGE2,
19R-hydroxy-PGE2,
19(R)-hydroxy Prostaglandin E2,
19(R)-hydroxy-Prostaglandin E2,
19R-19-Hydroxy PGE-2,
9-oxo-11R,15S,19R-trihydroxy-5Z,13E-prostadienoic acid,
64625-54-3,
(Z)-7-[(1R,2R,3R)-2-[(E,3S,7R)-3,7-dihydroxyoct-1-enyl]-3-hydroxy-5-oxocyclopentyl]hept-5-enoic acid,
19(R)-OH-PGE2,
19R-(OH)-PGE2,
AC1NR1DV,
19-OH-PGE2,
BML1-G11,
GTPL1947,
SCHEMBL2630490,
1279AH,
LMFA03010024,
ZINC12495318,
NCGC00161298-01,
SR-01000946845,
SR-01000946845-1,
9-Oxo-11R,15S,19R-trihydroxy-5Z,13E-prostadienoate,
Eganoprost,
D05MXO,
19-Hydroxyprostaglandin E2,
FA(20:2(OH3,Ke,cyclo)),
19 -HYDROXYPROSTAGLANDINE2,
C20H32O6,
CID5283038,